AMAG Pharmaceuticals, Inc. to Participate in the 2015 RBC Capital Markets’ Healthcare Conference

WALTHAM, Mass., Feb. 19, 2015 (GLOBE NEWSWIRE) — AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced that Frank Thomas, AMAG’s executive vice president and chief operating officer, will participate in an analyst-led fireside chat at the 2015 RBC Capital Markets’ Healthcare Conference on Tuesday, February 24, 2015 at 10:30 a.m. ET in New York, NY.

A live audio webcast of the discussion will be accessible through the Investors section of the company’s website at Following the conference, the webcast will be archived on the AMAG Pharmaceuticals, Inc. website for 30 days.

About AMAG

AMAG Pharmaceuticals, Inc. is a specialty pharmaceutical company with a focus on maternal health, anemia and cancer supportive care. The primary goal of AMAG is to bring to market therapies that provide clear benefits and improve patients’ lives. In addition to continuing to pursue opportunities to make new advancements in patients’ health and to enhance treatment accessibility, AMAG intends to continue to expand and diversify its portfolio through the in-license or purchase of additional pharmaceutical products or companies. For additional company information, please visit

CONTACT: AMAG Pharmaceuticals, Inc.:
         Katie Payne, 617-498-3303

AMAG Pharmaceuticals logo

AMAG Pharmaceuticals, Inc.